financetom
Business
financetom
/
Business
/
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Nvidia Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Set
Nov 20, 2024 7:41 PM

05:02 PM EST, 11/20/2024 (MT Newswires) -- (Updates the stock change in the last paragraph.)

Nvidia ( NVDA ) reported fiscal Q3 non-GAAP earnings late Wednesday of $0.81 per diluted share, up from $0.40 a year earlier.

Analysts polled by FactSet expected $0.75 excluding some items.

Revenue in the three months ended Oct. 27 rose to $35.08 billion from $18.12 billion a year earlier.

Analysts surveyed by FactSet expected $33.17 billion.

The company expects fiscal Q4 revenue of $37.5 billion, plus or minus 2%. Analysts expect $37.09 billion.

Nvidia ( NVDA ) shares fell 0.7% in after-hours activity, paring earlier losses.

Price: 144.81, Change: -1.08, Percent Change: -0.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
StanChart Q1 profit beats estimates as income boost outweighs China woes
StanChart Q1 profit beats estimates as income boost outweighs China woes
May 1, 2024
HONG KONG/LONDON (Reuters) -Standard Chartered PLC ( SCBFF ) beat forecasts on Thursday with a 5.5% rise in its first-quarter pretax profit, as the income boost from higher interest rates and a robust performance from its markets trading business offset a surge in credit losses. The bank, which makes the bulk of its revenue and profits in Asia, saw its...
BRIEF-Permira To Acquire Majority Position In Biocatch At $1.3 Bln Valuation
BRIEF-Permira To Acquire Majority Position In Biocatch At $1.3 Bln Valuation
May 1, 2024
May 2 (Reuters) - BioCatch: * PERMIRA TO ACQUIRE MAJORITY POSITION IN BIOCATCH AT $1.3BN VALUATION * BIOCATCH - UNDER THE TERMS OF THE AGREEMENT, THE FUND WILL ACQUIRE A MAJORITY STAKE IN BIOCATCH * BIOCATCH - TRANSACTION IS EXPECTED TO ACCELERATE THE COMPANY'S GLOBAL EXPANSION Source text for Eikon: Further company coverage: ...
FOCUS-British pharmacies vie for weight-loss patients with drug price cuts
FOCUS-British pharmacies vie for weight-loss patients with drug price cuts
May 1, 2024
* UK pharmacies cut prices for weight-loss drugs Wegovy, Mounjaro * Competition for customers raises concerns over patient aftercare * Users of the drugs need medical supervision By Ludwig Burger May 2 (Reuters) - Online pharmacies and slimming clinics are cutting prices for Wegovy and Mounjaro in Britain just months after the weight-loss drugs were launched there, as initial supply...
Standard Chartered Q1 profit rises 5.5%, beats estimates
Standard Chartered Q1 profit rises 5.5%, beats estimates
May 1, 2024
HONG KONG, May 2 (Reuters) - Standard Chartered PLC ( SCBFF ) posted on Thursday a 5.5% rise in its first-quarter pretax profit, beating estimates, as higher interest rates bolstered earnings at the emerging markets-focused lender. StanChart, which earns most of its revenue in Asia, said statutory pretax profit in the quarter was $1.91 billion. That compared with $1.81 billion...
Copyright 2023-2026 - www.financetom.com All Rights Reserved